1Fattly Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].实用肝脏病杂志,2007,10(1):1-3. 被引量：144
2梁扩寰,李绍白.肝脏病学[M].北京:人民卫生出版社,2006:644.
3Frazier T H, Stocker A M, Kershner N A, et al. Treatment of alcoholic liver disease [J ]. Therap Adv Gastroenterol, 2011, 4(1): 63.
4Caputo F, Bemardi M, Zoli G. Efficacy and safety of γ - hy- droxybutyrate in treating alcohol withdrawal syndrome in an alcohol- dependent inpatient with decompensated liver cir- rhosis: a case report[J]. J Clin Psyehopharrnacol, 2011, 31 (1): 140.
5Yang H Y, Lin H S, Chao J C, et al. Effects of soy protein on alcoholic liver disease in rats undergoing ethanol withdraw- al[J]. J Nutr Biochem, 2012, 23(6) : 679.
6Trabut J B, Thepot V, Nalpas B, et al. Rapid decline of liv- er stiffness following alcohol withdrawal in heavy drinkers [J]. Alcohol Clin Exp Re.s, 2012, 36(8) : 1407.
7Leggio L, Kenna G A, Ferrulli A, et al. Preliminary find- ings on the use of metadoxine for the treatmem of alcohol de- pendence andalcoholic liver disease[J]. Hum Psychopharma- col, 2011, 26(8): 554.
8Mao Y M, Zeng M D, Li Y M, et al. Capsule metadoxine in the treatment of alcoholic liver disease: a randomized, double - blind, placebo - controlled, multicenter study [ J ]. Zhonghua Gan Zang Bing Za Zhi, 2009, 17(3) : 213.
9Vali L, Blazovics A, Feher J. The therapeutic effect of metadoxine on alcoholic and non - alcoholic steatohepatitis [J]. Orv Hetil, 2005, 146(47): 2409.
10Su H L, Zhu Y X, Gao Z J, et al. Efficacy comparison be- tween bieyclol and polyene phosphatidyl choline treatments for the patients with nonalcoholic fatty liver disease [J ]. Zhon4ghua Gan Zang Bing Za Zhi, 2011, 19(7) : 552.
